US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Nasdaq Biotechnology

117.82

+1.221.04%

Volume:4K

Turnover:411.32K

Market Cap:102.50M

PE:- -

High:117.82

Open:117.15

Low:117.15

Close:116.60

52wk High:126.40

52wk Low:55.34

Shares:870.00K

Float Shares:870.00K

Volume Ratio:0.47

T/O Rate:0.40%

Dividend:0.33

Dividend Rate:0.28%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition

MT Newswires Live

Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals

Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027

Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team

THOMSON REUTERS

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

UK Regulator Suspends Avacopan Vifor for New Patients

MT Newswires Live

Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs

UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September

THOMSON REUTERS

Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?

Simply Wall St.

Vertex Advances Share Buyback, Acquires 445,500 Shares by August

Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run

Simply Wall St.

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Political and General News Events from August 31

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/BIB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"ProShares Ultra Nasdaq Biotechnology","latestPrice":117.815,"timestamp":1788287066920,"preClose":116.5968,"halted":0,"volume":3509,"delay":0,"changeRate":0.010447971127852531,"floatShares":870000,"shares":870000,"eps":0,"marketStatus":"Trading","change":1.2182,"latestTime":"09-01 14:25:12 EDT","open":117.15,"high":117.815,"low":117.15,"amount":411316.818066,"amplitude":0.005703,"askPrice":117.81,"askSize":100,"bidPrice":117.56,"bidSize":100,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":116.5968,"sharesOutstanding":1040000,"nav":116.3208,"aum":101199096,"dividendRate":0.002766,"bidAskSpread":0.003041,"preHourTrading":{"tag":"盘前","latestPrice":117.83,"preClose":116.5968,"latestTime":"08:59 EDT","volume":13,"amount":1531.79,"timestamp":1788267571078,"change":1.2332,"changeRate":0.010577,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":116.6,"preClose":116.5968,"latestTime":"19:30 EDT","volume":13,"amount":1515.464,"timestamp":1788219002070,"change":0.0032,"changeRate":0.000027,"amplitude":0},"volumeRatio":0.473209,"impliedVol":0.4367,"impliedVolPercentile":0.4167},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","floatShares":870000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.473209,"shares":870000,"dividePrice":0.3259,"high":117.815,"amplitude":0.005703,"preClose":116.5968,"low":117.15,"week52Low":55.34,"pbRate":"--","week52High":126.399,"institutionHeld":0,"latestPrice":117.815,"eps":0,"divideRate":0.002766,"volume":3509,"delay":0,"ttmEps":0,"open":117.15,"prevYearClose":79.7794,"prevWeekClose":116.3898,"prevMonthClose":116.5968,"prevQuarterClose":100.74,"fiveDayClose":125.1901,"twentyDayClose":100.17,"sixtyDayClose":80.2719},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIB\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"BIB","amount":0.00714,"announcedDate":"2026-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-25","defaultRemindTime":1774445400000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-25","currency":"USD","dateTimestamp":1774411200000,"payDate":"2026-03-31"},{"date":"2025-12-24","symbol":"BIB","amount":0.134637,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-31"},{"date":"2025-09-24","symbol":"BIB","amount":0.180541,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"BIB","amount":0.170576,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-07-01"},{"date":"2025-03-26","symbol":"BIB","amount":0.130939,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-04-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIB\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-22","recordDate":"2022-12-23","paymentDate":"2022-12-30","value":0.019852,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-28","value":0.038393,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-27","value":0.040324,"currency":"USD"},{"executeDate":"2024-06-26","recordDate":"2024-06-26","paymentDate":"2024-07-03","value":0.26476,"currency":"USD"},{"executeDate":"2024-09-25","recordDate":"2024-09-25","paymentDate":"2024-10-02","value":0.15285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664854756","title":"Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2664854756","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664854756?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:51","pubTimestamp":1788270662,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals  has completed its acquisition of Crinetics Pharmaceuticals , Vertex said on Tuesday.Following the acquisition's closing, Jonathan Poole will take over Vertex's chief financial officer role, effective Jan. 1, Vertex said. Poole currently serves as Vertex's senior vice president for finance, the company said.Charles Wagner, chief operating and financial officer of Vertex, will expand his COO role to head Crinetics' integration, effective immediately, Vertex said.Price: 549.07, Change: +4.55, Percent Change: +0.83","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","IE0002270589.USD","IE00B19Z9Z06.USD","IE00B2B36J28.USD","LU1069344957.HKD","LU1674673691.USD","LU2236285917.USD","BK4139","GNMX","IE00B19Z3B42.SGD","IE00B4R5TH58.HKD","TBXU","VRTX","LU1559883803.SGD","IE00B19Z9P08.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4567","PBE","CRNX","LU0432979614.USD","BIB","IE00B19Z3581.USD","LU0320765992.SGD","IE00B894F039.SGD","VERX","LU0289739699.SGD","LU0757428866.USD","LU1430594728.SGD","LU0079474960.USD","LU0823416689.USD","IE00BFTCPJ56.SGD","BK4533","LU0058720904.USD","LU0566484027.USD","IBB","IBBQ","LU1778281490.HKD","IDNA","LU2089984988.USD","LU0234570918.USD","LU2468319806.SGD","BBH","LU2362541273.HKD","LU2456880835.USD","LU1093756325.SGD","LU0889565916.HKD","LU0417517546.SGD","IE0009355771.USD","IE00BZ9MQY76.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664144854","title":"Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2664144854","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664144854?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:25","pubTimestamp":1788269142,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals (VRTX) announced the successful completion of the acquisition of Crinetics Pharmaceuticals (CRNX). Vertex also announced the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-completes-acquisition-of-crinetics-pharmaceuticals-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-completes-acquisition-of-crinetics-pharmaceuticals-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0234570918.USD","LU2362541513.USD","PBE","LU0079474960.USD","IE00B19Z9P08.USD","VERX","LU1093756325.SGD","CRNX","LU0889565916.HKD","IDNA","LU0432979614.USD","SGXZ57979304.SGD","SG9999013999.USD","LU1093756168.USD","LU1674673428.USD","LU2468319806.SGD","IE00B2B36J28.USD","SG9999001176.USD","IE00BJT1NW94.SGD","BK4007","LU0109394709.USD","IBBQ","BIB","LU0058720904.USD","BBH","IE0002141913.USD","IE00B4R5TH58.HKD","LU2236285917.USD","LU2462157665.USD","VRTX","LU0823416689.USD","LU2237438978.USD","IE00B894F039.SGD","LU1430594728.SGD","BK4567","LU0320765992.SGD","LU1035775433.USD","LU0757428866.USD","LU0256863811.USD","IBB","LU2089984988.USD","LU0061475181.USD","BK4023","LU0417517546.SGD","IE00B19Z3581.USD","IE00BJJMRZ35.SGD","IE00BZ9MQY76.HKD","TBXU","LU1815336091.USD","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664851485","title":"Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851485","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664851485?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:04","pubTimestamp":1788267895,"startTime":"0","endTime":"0","summary":"Vertex names Jonathan Poole CFO effective Jan. 1, 2027Vertex expanded its executive leadership team following the close of its Crinetics acquisition on Sept. 1, 2026.Charles Wagner, EVP and chief oper","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL4Tv8z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBE","EVLO","LU0289739699.SGD","IE0009355771.USD","BK4599","GNCAQ","BK4532","IBB","IE00B894F039.SGD","IE00BJT1NW94.SGD","LU1057294990.SGD","IE00B19Z3B42.SGD","PJP","SGXZ57979304.SGD","LU2468319806.SGD","LU2089984988.USD","SG9999013999.USD","AMGN","VRTX","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD","LU2462157665.USD","BK4139","BBH","IBBQ","IE00B2B36J28.USD","LU1585245621.USD","LU1093756325.SGD","IE00B19Z9P08.USD","TBXU","BK4581","LU1093756168.USD","LU2362540622.SGD","LU0234570918.USD","LU0061475181.USD","LU2362541273.HKD","LU0079474960.USD","LU0823416689.USD","GNMX","LU1023059063.AUD","LU0432979614.USD","BK4588","SG9999001176.USD","LU0109394709.USD","BK4567","LU1778281490.HKD","BIB","LU1035775433.USD","BK4566","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664117851","title":"Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team","url":"https://stock-news.laohu8.com/highlight/detail?id=2664117851","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664117851?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:03","pubTimestamp":1788267780,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nTUA44TDY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","IE00B19Z9P08.USD","IE0002270589.USD","LU0320765992.SGD","BIB","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","IBB","LU2236285917.USD","SG9999001176.SGD","GNMX","BK4585","IBBQ","BK4567","BK4139","LU1674673691.USD","SGXZ57979304.SGD","IE00B2B36J28.USD","IDNA","BK4588","LU1674673428.USD","IE0002141913.USD","IE00BZ9MQY76.HKD","TBXU","LU0823416689.USD","IE00B4R5TH58.HKD","IE00B894F039.SGD","LU1430594728.SGD","IE00B19Z9Z06.USD","VRTX","LU2417539215.USD","LU2468319806.SGD","LU0079474960.USD","LU1778281490.HKD","LU0234570918.USD","LU0432979614.USD","BK4532","LU1035775433.USD","LU2362541513.USD","BBH","LU1093756168.USD","LU2456880835.USD","IE0009355771.USD","LU1585245621.USD","IE00B19Z3581.USD","LU2237438978.USD","LU2324357040.USD","PBE","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664568448","title":"Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664568448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664568448?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:49","pubTimestamp":1788263354,"startTime":"0","endTime":"0","summary":"FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreementsSept 1 (Reuters)-U.S. President Donald Trump has struck drug-pricing deals with more than 20 pharmaceutical co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T0TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0477156953.USD","LU0553294199.USD","LU0820561909.HKD","IE00BSNM7G36.USD","LU0096364046.USD","LU1883839398.USD","LU0154236417.USD","LU0471298694.HKD","LU0225284248.USD","LU0225283273.USD","LU1059921491.USD","OZEM","LU0234570918.USD","LU0310800379.SGD","LU2750360641.GBP","SG9999014567.USD","LU2133065610.SGD","LU1699723380.USD","LU0345770308.USD","LU0980610538.SGD","LU0029864427.USD","LU1989771016.USD","BK4533","BK4592","LU1934455194.USD","IE0001KFT4U8.USD","LU0861579265.USD","LU1691799644.USD","LU0198837287.USD","LU0058720904.USD","LU0787776722.HKD","IE000F7OJYX1.SGD","LU2028103732.USD","LU2361045086.USD","LU1032955483.USD","LU0130517989.USD","LU0210528500.USD","LU0985320562.USD","PFE","FTXH","LU2023250330.USD","LU2271345857.HKD","LU0965509101.SGD","LU0889565916.HKD","LU0225771236.USD","LU2168564222.USD","IE0034235303.USD","LU1674673428.USD","SG9999015986.USD","LU1037948541.HKD","IE00BZ1G4Q59.USD","LU2112291526.USD","LU0726765562.USD","LU0109394709.USD","LU1718418525.SGD","LU2505996681.GBP","IE00BVYPNV92.GBP","LU1894683348.USD","ELIS","SG9999018857.SGD","SGXZ31699556.SGD","IE00BN8TJ469.HKD","IE00BFXG1179.USD","IE0004445015.USD","IXJ","LU0320765646.SGD","LU1236620750.USD","LU0708995401.HKD","IE00BK4W5M84.HKD","IE0002270589.USD","LU0053666078.USD","LU0323591593.USD","LU0266013472.USD","AZNH","IBBQ","LU1548497426.USD","LU0320765489.SGD","GB00BDT5M118.USD","LU0661504455.SGD","LU1829250122.USD","LU0124676726.USD","LU1974910355.USD","BK7067","NVOH","LU2125154778.USD","LU1162221912.USD","LU0466842654.USD","SG9999014906.USD","LU2491049909.HKD","LU1585245621.USD","SG9999015341.SGD","LU2746668974.SGD","IE00B4JS1V06.HKD","LLYX","SG9999017495.SGD","GDOC","JDOC","SG9999002232.USD","SG9999014559.SGD","LU0994945656.USD","SG9999015945.SGD","IE000WAW04H5.SGD","IE00BFTCPJ56.SGD","LU1221951046.USD","LU1670711123.USD","LU1868836757.USD","LU1366192091.USD","LU2896262040.SGD","LU1988902786.USD","LU1868836914.USD","LU2089283258.USD","LU2089284900.SGD","BK4585","LU1934455277.USD","IE00B775H168.HKD","LU1280957306.USD","LU1244550494.USD","IE000BZT7R73.USD","LU0795875169.SGD","LU1629891620.HKD","SG9999002224.SGD","LU0345770993.USD","LU0511384066.AUD","LU0882574055.USD","LU1057294990.SGD","LU1116320901.HKD","LU2552382058.USD","JNJ","LU2087625088.SGD","LU0683600562.USD","LU0648001328.SGD","LU2125909593.SGD","LU2089984988.USD","LU1571399168.USD","BIB","LLY","IE00BVYPNW00.USD","LU0395794307.EUR","IE00B2B36J28.USD","LU2750360997.AUD","RXL","LU0256863902.USD","LU0006306889.USD","LU1267930813.SGD","LU0820562030.AUD","LU0289739343.SGD","LU1923622614.USD","LU2468319806.SGD","LU0321505868.SGD","LU0267386448.USD","LU0321505439.SGD","LU1868837136.USD","LU2242652126.USD","IE000MB6IJN5.SGD","LU2168564495.EUR","LU0265550946.USD","LU0061475181.USD","LU0965508806.USD","04332","BK4578","LU1069344957.HKD","LU1236620834.HKD","LU2746668461.USD","IE00B19Z3581.USD","LLYZ","LU2237443622.USD","LU0417517546.SGD","SG9999015358.SGD","LU2106854487.HKD","LU0170899867.USD","IE00BBT3K403.USD","LU2487616109.SGD","LU1670710661.SGD","ELIL","LU1934455863.HKD","IE00BJJMRX11.SGD","LU2461242641.AUD","LU0432979614.USD","LU1551013425.SGD","LU0965509010.AUD","AMGN","LU0265550359.USD","SGXZ81514606.USD","IE000M9KFDE8.USD","IE0009355771.USD","LU0162691827.USD","LU1066051225.USD","REGN","IE00BJLML261.HKD","BBIO","LU2347655156.SGD","BK4550","ABBV","LU0316494557.USD","NVOX","SG9999014914.USD","LU2129689605.HKD","LU0859254822.USD","LU1023059063.AUD","LU1670711040.USD","LU1670628061.USD","LU1074936037.SGD","LU2471134796.USD","LU1127390331.HKD","IE000SO60NU8.SGD","SG9999013999.USD","LU2023251221.USD","IE00BDGV0183.EUR","LU1804176565.USD","LU1228905540.USD","GLAM","LU2347655073.USD","LU1116320737.USD","SG9999014575.USD","LU2602419157.SGD","LU1003077747.HKD","LU2756315318.SGD","AZN","LU2063271972.USD","IE00BN29S564.USD","LU0211327993.USD","NVS","LU1929549753.HKD","LU1267930730.SGD","IE00B19Z3B42.SGD","IE00BJJMRY28.SGD","LU0238689110.USD","LU0689472784.USD","IE00BLSP4452.SGD","LU1623119135.USD","LU0098860793.USD","LU0882574139.USD","LU1868837300.USD","VHT","LU1093756325.SGD","LU1935042991.SGD","PAWZ","LU1043141396.HKD","LU0097036916.USD","SGXZ57979304.SGD","LU2596442595.SGD","LU1066051811.HKD","LU0545562505.USD","LU1032466523.USD","LU1732799900.SGD","LU1989772923.USD","SG9999014542.SGD","LU0385154629.USD","CSL.AU","LU0109391861.USD","BK4568","LU0545039389.USD","LU0094547139.USD","AGNG","LU0345769631.USD","LU0472753341.HKD","LU0203345920.USD","LU0456855351.SGD","IE0002141913.USD","LU0203201768.USD","BK4007","LU2462157665.USD","LU1989772840.SGD","BK4566","LU2430703178.SGD","IE00BK4W5L77.USD","BK4588","LU1221951129.SGD","BMY","MEDX","LU0943347566.SGD","LU0203202063.USD","LU1551013342.USD","06160","GSK","IE00BKVL7J92.USD","LU1983299246.USD","PJP","LU0345769128.USD","LU1430594728.SGD","688235","GSKH","BK4504","BK4581","LU1061106388.HKD","LU0106261372.USD","LU0868494617.USD","LU2361044865.SGD","LU0211331839.USD","LU0426417589.USD","SG9999015978.USD","SGXZ99366536.SGD","LU0289961442.SGD","LU0203347892.USD","LU2552382215.SGD","LU2471134879.HKD","LU0237698245.USD","LU0158827948.USD","LU2236285917.USD","LU0320765992.SGD","LU2756315664.SGD","LU1066053197.SGD","LU2125909247.SGD","NVO","LU1201861249.SGD","LU0792757196.USD","LU0353189763.USD","LU0310799852.SGD","LU2430703095.HKD","LU2108987350.USD","LU2237443382.USD","LU1323610961.USD","LU1712237335.SGD","LU2552382132.HKD","GILD","LU1066051498.USD","LU2211815571.USD","LU0640476718.USD","LU0354030438.USD","SG9999003800.SGD","IE00BWXC8680.SGD","LU0306806265.USD","SGXZ80539844.SGD","LU2491050154.USD","MHIP","ONC","LU2242646821.SGD","LU2087621335.USD","SG9999001440.SGD","LU1670710588.SGD","LU1979441026.SGD","LU0985481810.HKD","IE00B4R5TH58.HKD","MEDI","BK4534","LU1196500208.SGD","LU2168563687.JPY","THNR","TBXU","IE00B1XK9C88.USD","LU0738911758.USD","LU0889566641.SGD","IE00BGHQF631.EUR","IE00B7SZLL34.SGD","LU2360032135.SGD","IE00BFSS8Q28.SGD","BK7511","LU0234572021.USD","LU2237438978.USD","LU1670627923.USD","LU0795875086.SGD","LU0128525929.USD","LU2168564065.EUR","SG9999011175.SGD","CANC","IE00BKDWB100.SGD","BBH","LU2433249047.HKD","LU0256863811.USD","LU2264538146.SGD","LU1035775433.USD","LU2125154935.USD","BK0239","LU0070217475.USD","LU1035773651.USD","LU1244550221.USD","LU2462591350.SGD","LU0823416689.USD","IE00B42XCP33.USD","LU1496350171.SGD","LU2403377893.USD","IE0005OL40V9.USD","LU0965509283.SGD","LU1069347547.HKD","LU0057025933.USD","HRTS","LU1267930573.SGD","SG9999001176.USD","BK4516","LU0158827781.USD","LLII","IE00B3T34201.USD","LU2237443895.HKD","LU0708994859.HKD","LU0289739699.SGD","BK4559","LU0672654240.SGD","LU1244550577.SGD","LU1291159041.SGD","IBB","XLV","BK4532","LU0070302665.USD","LU0211328371.USD","LU0320765059.SGD","FHLC","IE00BFSS7M15.SGD","LU1261432733.SGD","BK4599","LU2129689514.USD","SG9999001176.SGD","LU1093756168.USD","LU0823434583.USD","LU0868494708.USD","LU2237443978.SGD","LU0174119429.USD","GSK.UK","LU1064131342.USD","LU1732800096.USD","LU0823434740.USD","SGXZ51526630.SGD","LU1917777945.USD","LU0072461881.USD","LU0942090050.USD","WDNA","LU1267930490.SGD","LU2213496289.HKD","MRK","LU1941712264.USD","LU0133085943.USD","CURE","LU2111349929.HKD","SG9999014880.SGD","LU2417539215.USD","BK4583","LU0306807586.USD","LU0786609619.USD","SG9999014898.SGD","LU1496350502.SGD","LU0130102774.USD","LU2471134952.CNY","LU1121112475.USD","LU2592432038.USD","LU2265009873.SGD","LU0210536198.USD","LU1720051017.SGD","LU1232071149.USD","LU2471134523.USD","LU0689626769.HKD","LU1868836591.USD","LU2129689431.USD","LU1814569148.SGD","LU2237443549.SGD","IE0000B7K699.USD","BMED","ILDR","LU1037948897.HKD","PBE","LU2023250504.SGD","LU2324357040.USD","LU2237443465.HKD","LU1941712348.USD","LU0964807845.USD","SG9999015952.SGD","LU2357305700.SGD","LU1839511570.USD","LU0949170772.SGD","TRUH","LU0114720955.EUR","LU2360106947.USD","BK7501","IE00BJJMRZ35.SGD","IE0004445239.USD","LU0912757837.SGD","LU2362541273.HKD","LU0069063385.USD","LU1778281490.HKD","LU0353189680.USD","LU1674673691.USD","LU2430703251.USD","IE00BJT1NW94.SGD","LU2362540622.SGD","IE00B1BXHZ80.USD","LU2456880835.USD","SG9999018865.SGD","LU0208291251.USD","LU1506573853.SGD","BK4139","LU1720051108.HKD","IE00BKPKM429.USD","LU0122379950.USD","IE00B3PB1722.GBP","LU2505996509.AUD","TMED","IE00BLSP4239.USD","IYH","LU1228905037.USD","LU0079474960.USD","LU0471298777.SGD","LU0820561818.USD","IE00B7KXQ091.USD","LU2357627491.SGD","LU1894683264.USD","LU0354030511.USD","BK4505","LU1145028129.USD","LU2361044949.HKD","LU2362541513.USD","LU2168564149.EUR","LU1043141123.HKD","LU2491050071.SGD","LU1914381329.SGD","NVOC","IHE","BK7508","PPH","LU2023250843.SGD","LU0426412945.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664385377","title":"UK Regulator Suspends Avacopan Vifor for New Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2664385377","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664385377?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:03","pubTimestamp":1788260615,"startTime":"0","endTime":"0","summary":"The UK's health regulator has suspended the use, supply and sale of Avacopan Vifor, previously known as Tavneos, for new patients from Sept. 1, the watchdog said Tuesday.The Medicines and Healthcare products Regulatory Agency said available evidence no longer supports a positive benefit-risk balance for the medicine, which is used to treat some rare autoimmune diseases affecting small blood vessels.Tavneos was originally developed by ChemoCentryx, which was acquired by Amgen  in 2022, according to Amgen's website.The regulator said it reached its decision after reviewing all available evidence, advice from the Commission on Human Medicines, and feedback from patients and healthcare professionals.The supply will be allowed to existing patients during a six-month managed withdrawal period to allow safe alternative treatment options, the regulator said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B4R5TH58.HKD","LU2242646821.SGD","TBXU","PJP","IE0009355771.USD","LU0058720904.USD","IBB","BK4533","BK4581","LU0109394709.USD","BBH","LU0122379950.USD","LU0320765992.SGD","IE00B2B36J28.USD","BK4599","LU1571399168.USD","LU2468319806.SGD","BK4534","SG9999001440.SGD","LU2112291526.USD","LU0868494617.USD","LU0889565916.HKD","BK4139","BK4588","IE00BJT1NW94.SGD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU1983299246.USD","LU2089984988.USD","BIB","LU2242652126.USD","AMGN","IE0002141913.USD","BK4566","LU1061106388.HKD","PBE","IBBQ","IE00BFTCPJ56.SGD","BK4585","LU0289739699.SGD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664287830","title":"Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664287830","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664287830?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:40","pubTimestamp":1788255621,"startTime":"0","endTime":"0","summary":"Goldman Sachs analysts added Vertex Pharmaceuticals (VRTX) to the firm’s US Conviction List as part of its monthly update. Goldman believes Vertex ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-added-to-us-conviction-list-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-added-to-us-conviction-list-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2236285917.USD","IE00BSNM7G36.USD","IE00BZ9MQY76.HKD","PBE","IE0002141913.USD","BK4504","LU2471134952.CNY","LU2362541273.HKD","IE00BFTCPJ56.SGD","LU1868836914.USD","IBBQ","LU0345770993.USD","LU2362540622.SGD","BIB","LU1778281490.HKD","LU0432979614.USD","LU0757428866.USD","IE00BJT1NW94.SGD","LU2471134796.USD","LU1430594728.SGD","LU2237443895.HKD","LU1815336091.USD","LU0417517546.SGD","IE0004091025.USD","IE0002270589.USD","LU2237443382.USD","VERX","IBB","LU1668664300.SGD","LU1035775433.USD","IE00B19Z3581.USD","LU1093756325.SGD","IE00B2B36J28.USD","LU1894683264.USD","IE00B894F039.SGD","BK4127","IDNA","LU0106831901.USD","LU0868494708.USD","BBH","LU2471134879.HKD","LU2362541513.USD","SGXZ57979304.SGD","TBXU","GSX","LU1585245621.USD","VRTX","GNMX","LU2089984988.USD","IE0034235188.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664837149","title":"UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September","url":"https://stock-news.laohu8.com/highlight/detail?id=2664837149","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664837149?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:29","pubTimestamp":1788254980,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44S0UF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TBXU","BK4534","LU1571399168.USD","LU2112291526.USD","IBBQ","LU2242646821.SGD","LU0889565916.HKD","LU2089984988.USD","LU0320765992.SGD","LU1023059063.AUD","BK4533","IE00BJJMRZ35.SGD","BK4139","IE00BFTCPJ56.SGD","BBH","LU0109394709.USD","IE0009355771.USD","IBB","PJP","LU1061106388.HKD","LU2242652126.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","SG9999001440.SGD","BK4588","LU0289739699.SGD","LU1057294990.SGD","BK4599","PBE","LU0868494617.USD","BK4566","LU0058720904.USD","AMGN","BK4585","BK4581","LU1983299246.USD","IE0002141913.USD","IE00B2B36J28.USD","LU0122379950.USD","BIB","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664832384","title":"Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664832384","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664832384?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:18","pubTimestamp":1788250703,"startTime":"0","endTime":"0","summary":"Amgen (NasdaqGS:AMGN) reported new Phase 3 VESALIUS-CV trial results for Repatha (evolocumab) showing a reduction in risk of death for high-risk adults without prior heart attack or stroke, presented at the European Society of Cardiology Congress 2026.\nThe findings extend evidence for Repatha to a broader high-risk population beyond patients with established cardiovascular events.\nAmgen highlighted that the data may inform future treatment guidelines and prescribing decisions in...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/why-is-amgen-amgn-in-focus-after-new-repatha-survival-data","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/why-is-amgen-amgn-in-focus-after-new-repatha-survival-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE0009355771.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","BK4533","IE00B2B36J28.USD","LU1057294990.SGD","PJP","BK4566","BK4585","TBXU","BBH","LU0320765992.SGD","BIB","SG9999001440.SGD","LU0058720904.USD","LU0109394709.USD","LU2089984988.USD","LU1983299246.USD","IBB","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU1061106388.HKD","PBE","IBBQ","LU1023059063.AUD","BK4599","LU2112291526.USD","LU0122379950.USD","LU2242646821.SGD","LU0289739699.SGD","BK4588","BK4139","LU2468319806.SGD","LU0889565916.HKD","IE0002141913.USD","IE00BJT1NW94.SGD","LU2242652126.USD","AMGN","BK4581","BK4534","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838571","title":"Vertex Advances Share Buyback, Acquires 445,500 Shares by August","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838571","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838571?lang=en_us&edition=fundamental","pubTime":"2026-09-01 12:22","pubTimestamp":1788236545,"startTime":"0","endTime":"0","summary":"Vertex Corp. ( ($JP:5290) ) has provided an announcement. Vertex Corporation reported the progress of its ongoing share buyback program, authorized...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBE","LU2456880835.USD","LU1035775433.USD","BK4139","LU1430594728.SGD","ACKY","LU1069344957.HKD","LU0417517546.SGD","IE0002141913.USD","BRKC","GNMX","LU0061475181.USD","BK4588","IDNA","IE00BFTCPJ56.SGD","BRKD","LU1674673428.USD","LU1559883803.SGD","VRTX","BIB","LU2468319806.SGD","IBB","IBBQ","LU0320765992.SGD","LU0109394709.USD","VERX","BRKU","LU2362541513.USD","TBXU","IE00BZ9MQY76.HKD","BBH","LU0757428866.USD","BK4567","BRKW","LU0234570918.USD","SG9999001176.USD","ACTV","IE00BJJMRZ35.SGD","LU0058720904.USD","IE00B19Z9P08.USD","LU0889565916.HKD","LU2237438978.USD","LU1585245621.USD","LU2462157665.USD","BRKL","IE00BJT1NW94.SGD","LU0256863811.USD","LU1778281490.HKD","IE00B2B36J28.USD","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838493","title":"Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838493","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838493?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:20","pubTimestamp":1788229256,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals has delivered strong long term gains over the past five years, yet current valuation checks suggest the stock now looks closer to fairly priced than clearly cheap. For investors, the question is how that past share price performance lines up with what the broader valuation signals are saying today.\n\nThe stock has returned 174.9% over five years, which puts extra focus on whether recent strength already reflects much of the good news in the story.\nFuture growth in cash...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1559883803.SGD","IE00BJJMRZ35.SGD","GNMX","IE00B19Z3B42.SGD","BBH","LU1430594728.SGD","BK4139","LU0079474960.USD","IBBQ","LU0289739699.SGD","LU1815336091.USD","LU2362540622.SGD","SG9999001176.USD","LU2089984988.USD","BK4588","TSPA","VRTX","TBXU","PBE","LU0109394709.USD","LU1069344957.HKD","BK4532","IBB","LU0823416689.USD","SG9999001176.SGD","BIB","VERX","LU0061475181.USD","LU2417539215.USD","LU0432979614.USD","BK4585","LU1035775433.USD","LU1674673428.USD","IE0002141913.USD","IE00B19Z9Z06.USD","LU0234570918.USD","SGXZ57979304.SGD","LU1778281490.HKD","LU2324357040.USD","LU1674673691.USD","IE00BZ9MQY76.HKD","IDNA","TACU","CDIG","LU0566484027.USD","LU0889565916.HKD","LU1093756168.USD","IE0009355771.USD","IE00B19Z3581.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664925888","title":"Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2664925888","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664925888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:53","pubTimestamp":1788205998,"startTime":"0","endTime":"0","summary":"UPDATE 2-Trump administration announces drug pricing deals with CSL, Astellas and othersWASHINGTON, Aug 31 (Reuters)-U.S. President Donald Trump announced a new round of drug-pricing agreements with i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0RA:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","LU1983299246.USD","LU1057294990.SGD","BK0046","BK4550","300485","IE00BLSP4239.USD","LU2112291526.USD","SG9999002224.SGD","CSL.AU","BK4505","BK4534","LU0109394709.USD","IE00B3T34201.USD","BIB","LU1883839398.USD","LU0868494617.USD","LU1894683348.USD","IE00BLSP4452.SGD","BK0028","BBIO","IBBQ","BK4566","LU0320765992.SGD","688235","TBXU","BBH","PFE","LU2242646821.SGD","IE00BJT1NW94.SGD","BK4007","OZEM","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","PJP","AMGN","IE0002270589.USD","LU0225284248.USD","LU0889565916.HKD","IE0002141913.USD","LU0306806265.USD","SGXZ57979304.SGD","PBE","IBB","LU0321505439.SGD","BK7511","SG9999001176.SGD","LU2468319806.SGD","IONS","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663005748","title":"Political and General News Events from August 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2663005748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663005748?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:15","pubTimestamp":1788182117,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 31Aug 31 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S10Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU2089984988.USD","PJP","LU2242652126.USD","IE0009355771.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","BK4534","LU1571399168.USD","IBB","LU0289739699.SGD","TBXU","LU0889565916.HKD","BK4533","IE00BJT1NW94.SGD","BIB","LU2468319806.SGD","LU0868494617.USD","BK4581","PBE","IE0002141913.USD","LU1023059063.AUD","BK4599","SG9999001440.SGD","BK4588","LU2112291526.USD","IBBQ","BBH","IE00BFTCPJ56.SGD","LU0058720904.USD","LU2242646821.SGD","AMGN","LU0122379950.USD","BK4585","LU1983299246.USD","IE00BJJMRZ35.SGD","LU1057294990.SGD","BK4139","LU1061106388.HKD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071381","title":"Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071381","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663071381?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:51","pubTimestamp":1788169915,"startTime":"0","endTime":"0","summary":"Amgen  said Monday that its cholesterol-lowering drug Repatha reduced the risk of death by 20% in high-risk adults without a prior heart attack or stroke.The findings came from a pre-specified analysis of the phase 3 VESALIUS-CV trial involving more than 12,000 patients and were presented at the European Society of Cardiology Congress 2026 in Munich, it said.Amgen said Repatha reduced both overall and cardiovascular deaths when added to statins or other LDL-C-lowering treatments. The mortality benefit emerged after about 1.5 years and continued through a median follow-up of 4.6 years, it added.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0289739699.SGD","IBB","LU2468319806.SGD","BK4599","LU2089984988.USD","LU2242646821.SGD","LU0320765992.SGD","BK4581","LU1057294990.SGD","IE00BJJMRZ35.SGD","BK4566","PJP","LU0058720904.USD","BK4534","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0868494617.USD","LU2112291526.USD","IE00BJT1NW94.SGD","IE0002141913.USD","BIB","IBBQ","LU1983299246.USD","AMGN","LU2242652126.USD","LU1571399168.USD","SG9999001440.SGD","LU1023059063.AUD","TBXU","IE0009355771.USD","LU0122379950.USD","LU1061106388.HKD","PBE","LU0889565916.HKD","LU0109394709.USD","BK4139","BK4585","BBH","BK4533","IE00BFTCPJ56.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663249076","title":"Amgen Repatha reduces risk of death in high-risk adults for first heart attack","url":"https://stock-news.laohu8.com/highlight/detail?id=2663249076","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663249076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:10","pubTimestamp":1788167413,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) announced new findings showing Repatha reduced the risk of death in high-risk adults without a prior heart attack or stroke when added...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002141913.USD","PBE","IBBQ","LU2089984988.USD","IBB","LU0058720904.USD","IE00B4R5TH58.HKD","BK4585","LU0289739699.SGD","LU1057294990.SGD","BK4566","LU0868494617.USD","PJP","LU1571399168.USD","AMGN","BK4139","LU2242646821.SGD","LU0889565916.HKD","IE0009355771.USD","BK4581","BBH","LU2468319806.SGD","TBXU","IE00BFTCPJ56.SGD","LU1983299246.USD","BK4533","IE00B2B36J28.USD","BK4534","LU0320765992.SGD","LU1061106388.HKD","LU2112291526.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4588","LU0122379950.USD","BK4599","IE00BJT1NW94.SGD","BIB","SG9999001440.SGD","LU1023059063.AUD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663202044","title":"Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke","url":"https://stock-news.laohu8.com/highlight/detail?id=2663202044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663202044?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:18","pubTimestamp":1788160736,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA6XK0BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B4R5TH58.HKD","IBBQ","BBH","PBE","IE0009355771.USD","LU1023059063.AUD","LU1983299246.USD","LU0058720904.USD","BK4139","LU2089984988.USD","LU0289739699.SGD","BK4533","LU1057294990.SGD","LU0868494617.USD","SG9999001440.SGD","LU0122379950.USD","AMGN","IBB","IE0002141913.USD","LU2112291526.USD","IE00BJJMRZ35.SGD","BK4581","BIB","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4588","PJP","LU0320765992.SGD","TBXU","BK4585","BK4599","LU1571399168.USD","IE00BJT1NW94.SGD","LU0109394709.USD","LU2242646821.SGD","LU0889565916.HKD","LU2468319806.SGD","LU2242652126.USD","LU1061106388.HKD","BK4534","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663043488","title":"Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043488","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663043488?lang=en_us&edition=fundamental","pubTime":"2026-08-30 07:30","pubTimestamp":1788046226,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong gains over the past few years, yet current valuation checks still suggest the shares screen as inexpensive on several metrics. The question for investors is how that strong track record and the latest product approvals align with a profile that continues to lean cheap.\n\nOver 5 years the stock has returned about 143%, which puts recent moves in the context of a long, powerful run that investors now need to judge against today’s pricing.\nThe...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1571399168.USD","BMED","GILD","BK4583","LU1934455277.USD","LU0058720904.USD","BK4550","LU1934455863.HKD","LU1430594728.SGD","BK4578","BK4566","LU0114720955.EUR","LU1839511570.USD","LU0965508806.USD","LU0234570918.USD","LU2089984988.USD","BBH","LU1934455194.USD","LU0965509010.AUD","BK4532","LU1585245621.USD","LU1066051498.USD","IE00B3T34201.USD","MEDI","LU0122379950.USD","LU1066053197.SGD","IBBQ","BK4568","LU2468319806.SGD","LU2112291526.USD","BK4139","IBB","LU1023059063.AUD","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU0823416689.USD","SG9999015945.SGD","BK4585","LU2324357040.USD","BK4588","LU0882574055.USD","LU0965509283.SGD","TMED","IE00B19Z3B42.SGD","LU0109394709.USD","BIB","IE00BKVL7J92.USD","LU0289739699.SGD","SG9999015978.USD","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015099","title":"Crinetics Shareholders Approve Vertex Acquisition at Special Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015099","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015099?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:33","pubTimestamp":1787952818,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals ( ($CRNX) ) has provided an update. On August 28, 2026, Crinetics Pharmaceuticals shareholders held a special meeting at ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999001176.SGD","LU2468319806.SGD","BK4532","IBBQ","BIB","LU2417539215.USD","IE0009355771.USD","IE0002141913.USD","LU1674673691.USD","BBH","LU1778281490.HKD","IE00B894F039.SGD","LU0061475181.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","BK4585","BK4567","LU0079474960.USD","LU1069344957.HKD","LU2462157665.USD","IDNA","LU0432979614.USD","LU2236285917.USD","IE00BJJMRZ35.SGD","LU2324357040.USD","TBXU","LU0256863811.USD","LU1815336091.USD","LU2362540622.SGD","LU1093756168.USD","LU1674673428.USD","BK4023","LU0289739699.SGD","IE00BZ9MQY76.HKD","IE00B19Z9P08.USD","LU1430594728.SGD","IE00BFTCPJ56.SGD","GNMX","LU0823416689.USD","BK4588","LU0234570918.USD","PBE","LU0757428866.USD","IBB","VERX","BK4533","IE00BJT1NW94.SGD","VRTX","IE00B19Z3581.USD","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663701587","title":"Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663701587","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663701587?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:35","pubTimestamp":1787949300,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slid 2.14% to $145.68 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.Gilead Sciences Inc. closed 7.38% short of its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and Abbott Laboratories  rose 0.79% to $112.47.Trading volume  remained 3.2 million below its 50-day average volume of 7.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU0861579265.USD","IBB","LU1839511570.USD","SG9999015952.SGD","SG9999015978.USD","LU1061106388.HKD","LU0320765992.SGD","LU1066051498.USD","IE00B19Z3B42.SGD","LU1571399168.USD","SG9999015986.USD","IE00B19Z3581.USD","IE0002270589.USD","LU0289739699.SGD","LU0965509101.SGD","BK4588","LU2112291526.USD","IE00BSNM7G36.USD","LU1037948897.HKD","LU1066053197.SGD","LU2357627491.SGD","BBH","MEDI","IE00B3T34201.USD","IBBQ","LU0109394709.USD","LU0965508806.USD","LU1934455277.USD","LU2087621335.USD","LU0058720904.USD","LU0965509010.AUD","BK4532","LU0882574055.USD","BK4566","LU1430594728.SGD","LU1037948541.HKD","IE00B7SZLL34.SGD","SG9999015945.SGD","GILD","BMED","LU1057294990.SGD","LU1585245621.USD","LU2468319806.SGD","LU0122379950.USD","LU0234570918.USD","LU0859254822.USD","BK4583","LU0889565916.HKD","LU1778281490.HKD","LU2324357040.USD","LU0823416689.USD","BK4585","BK4139","BK4578","IE00BZ1G4Q59.USD","LU1023059063.AUD","BK4568","IE00BKVL7J92.USD","LU1674673691.USD","LU0114720955.EUR","LU1934455863.HKD","LU2089984988.USD","TMED","LU1674673428.USD","TBXU","LU0965509283.SGD","BIB","LU1934455194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015807","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015807","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015807?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:34","pubTimestamp":1787949240,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  slipped 1.05% to $432.42 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.This was the stock's fourth consecutive day of losses.Amgen Inc. closed 3.27% below its 52-week high of $447.03, which the company reached on August 25th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and AbbVie Inc.  fell 1.03% to $255.48.Trading volume  remained 889,592 below its 50-day average volume of 2.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4585","LU0109394709.USD","LU1061106388.HKD","LU0889565916.HKD","LU1571399168.USD","BK4581","LU0320765992.SGD","LU2112291526.USD","IE00B2B36J28.USD","BK4534","IE00BJT1NW94.SGD","IBB","LU0122379950.USD","BK4533","PJP","LU0058720904.USD","LU2089984988.USD","BK4566","BBH","LU0868494617.USD","LU1023059063.AUD","TBXU","SG9999001440.SGD","IE0002141913.USD","LU1983299246.USD","BIB","BK4588","LU2242646821.SGD","IE00BJJMRZ35.SGD","LU2468319806.SGD","PBE","LU1057294990.SGD","IBBQ","LU2242652126.USD","04332","LU0289739699.SGD","IE0009355771.USD","BK4599","AMGN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}